WPG Advisers’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$58.3K Sell
745
-100
-12% -$8.07K 0.03% 274
2026
Q1
$73.2K Sell
845
-109
-11% -$10.4K 0.05% 197
2025
Q4
$91.6K Sell
954
-91
-9% -$8.84K 0.07% 179
2025
Q3
$99.5K Sell
1,045
-4
-0.4% -$368 0.08% 163
2025
Q2
$91.4K Sell
1,049
-24
-2% -$2.04K 0.08% 173
2025
Q1
$96.4K Sell
1,073
-500
-32% -$44.7K 0.09% 167
2024
Q4
$126K Buy
+1,573
New +$136K 0.12% 148

Other funds holding MDT

WPG Advisers's MDT Position: Q2 2026 in Review

WPG Advisers reduced its Medtronic (MDT) stake by 12% in Q2 2026, selling an estimated $8.07K and leaving 745 shares worth $58.3K. The position accounts for 0.03% of the portfolio, ranked #274.

WPG Advisers first reported a position in MDT in Q4 2024 and has held it in 7 quarters since. The position peaked at $126K in Q4 2024. 1,329 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • WPG Advisers held 745 shares of Medtronic worth $58.3K as of Q2 2026.
  • WPG Advisers sold 100 Medtronic shares in Q2 2026, an estimated $8.07K.
  • Medtronic made up 0.03% of WPG Advisers's portfolio in Q2 2026, its #274 holding.
  • WPG Advisers first reported a position in Medtronic in Q4 2024 and has held it in 7 quarters since.
  • WPG Advisers's Medtronic position peaked at $126K in Q4 2024.
  • 1,329 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.